Network Meta-analysis of Ravulizumab and Alternative Interventions for the Treatment of Neuromyelitis Optica Spectrum Disorder

Abstract Introduction Anti-aquaporin-4 antibody-positive (AQP4-Ab+) neuromyelitis optica spectrum disorder (NMOSD) is a complement-mediated autoimmune disease in which unpredictable and relapsing attacks on the central nervous system cause irreversible and accumulating damage. Comparative efficacy o...

Description complète

Détails bibliographiques

Auteurs principaux:	Stacey L. Clardy, Sean J. Pittock, Orhan Aktas, Jin Nakahara, Noriko Isobe, Diego Centonze, Sami Fam, Adrian Kielhorn, Jeffrey C. Yu, Jeroen Jansen, Ina Zhang
Format:	Artigo
Langue:	Inglês
Publié:	Adis, Springer Healthcare 2024-05-01
Collection:	Neurology and Therapy
Sujets:	Neuromyelitis optica Aquaporin-4 Network meta-analysis Ravulizumab Eculizumab Inebilizumab
Accès en ligne:	https://doi.org/10.1007/s40120-024-00597-7
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!